Loading...
Back to narrative

Update shared on 25 Oct 2025

Fair value Increased 1.40%
AnalystConsensusTarget's Fair Value
US$41.17
4.9% overvalued intrinsic discount
25 Oct
US$43.18
Loading
1Y
18.4%
7D
5.0%

Cadre Holdings' analyst price target has been raised from $40.60 to $41.17. Analysts cite increased confidence in the company's nuclear safety platform and long-term growth opportunities highlighted at its recent investor day.

Analyst Commentary

Following Cadre Holdings' recent investor day, analysts have adjusted their perspectives on the company's outlook, particularly in relation to its growth trajectory in the nuclear safety platform and its overall valuation.

Bullish Takeaways
  • Bullish analysts have increased their price targets, reflecting enhanced confidence in Cadre's long-term growth prospects following new insights into its nuclear safety platform.
  • The newly organized Nuclear Group is seen as a significant contributor to future expansion, offering a long runway for growth. This is especially relevant given ongoing cleanup initiatives and potential opportunities in energy production linked to emerging technologies such as AI.
  • Analysts note that the unveiling of detailed information about the nuclear segment addresses previous market uncertainties. This helps clarify its value and strategic impact within the company's business model.
  • There is continued optimism toward Cadre's core business execution, with recent performance supporting the elevated outlooks and buy ratings from multiple research firms.
Bearish Takeaways
  • Bearish analysts remain cautious about the ability of Cadre to sustain growth rates in the nuclear segment, especially as the business transitions from being a relatively opaque part of the company to a prominent growth driver.
  • Some concern persists regarding execution risks associated with integrating the newly organized Nuclear Group and whether anticipated sector growth will materialize as projected.
  • Despite more transparency, there are lingering questions about the scalability of Cadre's solutions and the predictability of revenue contributions from the nuclear safety platform in the competitive landscape.

What's in the News

  • Cadre Holdings hosted an Analyst/Investor Day to highlight its record of value creation, discuss strategic execution, outline its operating model, and present a five-year vision supported by long-term industry growth drivers (Key Developments).
  • The company issued full-year 2025 earnings guidance, projecting net sales between $624 million and $630 million (Key Developments).

Valuation Changes

  • Consensus Analyst Price Target has risen slightly from $40.60 to $41.17, which reflects marginally increased confidence in future value.
  • Discount Rate has fallen modestly from 8.18% to 8.12%. This indicates a slightly lower required return and reduced risk perception.
  • Revenue Growth estimates remain essentially unchanged at 8.10%.
  • Net Profit Margin projections have edged down from 10.15% to 10.12%.
  • Future P/E Ratio has increased modestly from 28.00x to 28.43x. This suggests the market expects somewhat stronger earnings relative to price.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.